Intellectual Property Cases filed in New Jersey
ACTELION PHARMACEUTICALS LTD. et al v. BRISTOL-MYERS SQUIBB CO. et al
as 2:2021cv18695
Plaintiff: ACTELION PHARMACEUTICALS LTD. and ACTELION PHARMACEUTICALS US, INC.
Defendant: BRISTOL-MYERS SQUIBB CO., CELGENE CORP. and CELGENE INTERNATIONAL II SARL
Cause Of Action: 15 U.S.C. § 1126
ACTELION PHARMACEUTICALS LTD. et al v. BRISTOL-MYERS SQUIBB CO. et al
as 3:2021cv18695
Plaintiff: ACTELION PHARMACEUTICALS LTD. and ACTELION PHARMACEUTICALS US, INC.
Defendant: BRISTOL-MYERS SQUIBB CO., CELGENE CORP. and CELGENE INTERNATIONAL II SARL
Cause Of Action: 15 U.S.C. § 1126
BRISTOL-MYERS SQUIBB CO. v. TEVA PHARMACEUTICALS USA, INC.
as 3:2020cv03229
Defendant: TEVA PHARMACEUTICALS USA, INC.
Plaintiff: BRISTOL-MYERS SQUIBB CO.
Cause Of Action: 35 U.S.C. § 271
MERCK SHARP & DOHME CORP. v. BRISTOL-MYERS SQUIBB CO. et al
as 2:2016cv02122
Plaintiff: MERCK SHARP & DOHME CORP.
Defendant: BRISTOL-MYERS SQUIBB CO. , E.R. SQUIBB & SONS, L.L.C. and ONO PHARMACEUTICAL CO., LTD.
Cause Of Action: 35 U.S.C. § 271
RESONANT BIOTECHNOLOGIES, LLC v. SRU BIOSYSTEMS, INC. et al
as 3:2011cv04570
Plaintiff: RESONANT BIOTECHNOLOGIES, LLC
Defendant: SRU BIOSYSTEMS, INC., CALIPER LIFE SCIENCES, INC., NOVASCREEN BIOSCIENCES CORP. and others
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?